ApprovalTrail

Approval · Notice of Compliance 24797 · 2020

AURIMIC: Notice of Compliance 24797

Issued December 15, 2020

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
24797
Date
December 15, 2020
Product type
Veterinary
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Other
Canadian reference product
SUROLAN (Elanco, Division Of Eli Lilly Canada Inc.)

Products in this notice

BrandDINStatus today
AURIMIC02509725Marketed

Medicinal ingredients